1.4 billion adults aged 30 to 79 had hypertension in 2024, two-thirds of them in low- and middle-income countries. 630 million are diagnosed and treated. 320 million have it controlled.
Diabetes reached 589 million adults in 2024, 81% of them in low- and middle-income countries. 47 of these 344 molecules sit in the SGLT2 and DPP-4 classes.
Range depth
24 SGLT2 and 33 DPP-4 presentations, 10 of them combining both.
Rivaroxaban in 7 presentations, dabigatran in 5, apixaban in 4.
22 telmisartan presentations.
Tell us the market and what you already stock.
Start the conversation